1.Liu X, Liu W, Wu Y, Wang Y, Jiang Q, Li Y, Li H, Hao L. Investigation of the cytotoxic effects and mechanisms of the SLC39A6-targeting ADC drug BRY812 in CRC. Sci Rep. 2025 May 25;15(1):18275. doi: 10.1038/s41598-025-03713-1. PMID: 40414981; PMCID: PMC12104431.
2.Ghaderi H, Noormohammadi Z, Habibi-Anbouhi M, Kazemi-Lomedasht F, Behdani M. Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein. Iran J Basic Med Sci. 2021 Dec;24(12):1726-1733. doi: 10.22038/IJBMS.2021.58542.13003. PMID: 35432806; PMCID: PMC8976899.